Anzeige
Meldung des Tages: Deep-Value-Chance: 60 % Insideranteil – warum dieser Gold-Explorer als Geheimtipp gilt

Takeda Pharmaceutical Aktie (ADR) News

Aktie
WKN:  A1CWZF ISIN:  US8740602052 US-Symbol:  TAK Branche:  Pharmazeutika Land:  Japan
15,00 €
+0,2 €
+1,35%
09:44:02 Uhr
Depot/Watchlist
Marktkapitalisierung *
42,14 Mrd. €
Streubesitz
97,28%
KGV
64,95
Dividende
0,096 €
Dividendenrendite
1,73%
Faktor
2
Originalaktie
JP3463000004

Takeda Pharmaceutical Aktie (ADR) News

28.08.25 - PR Newswire
Takeda's FRUZAQLA™ (fruquintinib) publicly reimbursed in Quebec for the treatment of metastatic colorectal cancer (mCRC)
Takeda's FRUZAQLA™ (fruquintinib) publicly reimbursed in Quebec for the treatment of metastatic colorectal cancer (mCRC) Canada NewsWire
24.02.25 - PR Newswire
The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO® (lanadelumab) for Patients Aged 12 Years and Above with Recurrent Attacks of Hereditary Angioedema (HAE)
The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO® (lanadelumab) for Patients Aged 12 Years and Above with ...
24.02.25 - PR Newswire
Die Europäische Arzneimittelagentur (EMA) hat eine zusätzliche Option zur subkutanen Verabreichung von TAKHZYRO® (Lanadelumab) für Patienten ab 12 Jahren mit wiederkehrenden Attacken des hereditären Angioödems (HAE) genehmigt
Die Europäische Arzneimittelagentur (EMA) hat eine zusätzliche Option zur subkutanen Verabreichung von TAKHZYRO® (Lanadelumab) für Patienten ab 12 Jahren mit ...
24.02.25 - PR Newswire
The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO® (lanadelumab) for Patients Aged 12 Years and Above with Recurrent Attacks of Hereditary Angioedema (HAE)
The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO® (lanadelumab) for Patients Aged 12 Years and Above with ...

Newssuche

Videos

newspaper
02.02.26 -29,21%
Technical Trading Silber Crash!
Silber Short Typ: Turbo Open End WKN: VJ4GQU Hebel: 3,77 Laufzeit: OpenEnd Einstieg: Market ... Mehr »